Pieter Annaert

10.0k total citations
237 papers, 7.6k citations indexed

About

Pieter Annaert is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Infectious Diseases. According to data from OpenAlex, Pieter Annaert has authored 237 papers receiving a total of 7.6k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Oncology, 73 papers in Pediatrics, Perinatology and Child Health and 53 papers in Infectious Diseases. Recurrent topics in Pieter Annaert's work include Drug Transport and Resistance Mechanisms (87 papers), Pharmacological Effects and Toxicity Studies (42 papers) and HIV/AIDS drug development and treatment (34 papers). Pieter Annaert is often cited by papers focused on Drug Transport and Resistance Mechanisms (87 papers), Pharmacological Effects and Toxicity Studies (42 papers) and HIV/AIDS drug development and treatment (34 papers). Pieter Annaert collaborates with scholars based in Belgium, Netherlands and United States. Pieter Annaert's co-authors include Patrick Augustijns, Joachim Brouwers, Jan Tack, Raf Mols, Johan A. Martens, Jan Van Humbeeck, Guy Van den Mooter, Guy Van den Mooter, Randy Mellaerts and Isabel Spriet and has published in prestigious journals such as SHILAP Revista de lepidopterología, Hepatology and The Journal of Physiology.

In The Last Decade

Pieter Annaert

225 papers receiving 7.4k citations

Peers

Countries citing papers authored by Pieter Annaert

Since Specialization

Citations

This map shows the geographic impact of Pieter Annaert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pieter Annaert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pieter Annaert more than expected).

Fields of papers citing papers by Pieter Annaert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pieter Annaert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pieter Annaert. The network helps show where Pieter Annaert may publish in the future.

Co-authorship network of co-authors of Pieter Annaert

This figure shows the co-authorship network connecting the top 25 collaborators of Pieter Annaert. A scholar is included among the top collaborators of Pieter Annaert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pieter Annaert. Pieter Annaert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Mathematical Albumin Function for Neonates Undergoing Therapeutic Hypothermia in Comparison with Control Neonates 2025 ·The Journal of Clinical Pharmacology ·(unknown), (unknown), Pieter Annaert, Paul Clarke, Isabel Iglesias‐Platas, (unknown), (unknown), Annouschka Laenen, Nadir Yalçın, Anne Smits, Karel Allegaert	0
2	Predicting Drug Transfer Into Human Milk With the Simcyp Simulator: A Contribution From the ConcePTION Project 2025 ·CPT Pharmacometrics & Systems Pharmacology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Anne Smits, Karel Allegaert, Hedvig Nordeng, (unknown), Frederico Severino Martins, Pieter Annaert	0
3	PBPK/PD Model of Vancomycin in Sepsis: Linking Interstitial Exposure in Perfusion-Limited Tissues to MRSA Infection 2025 ·Pharmaceutics ·(unknown), José A. Lemos, (unknown), (unknown), (unknown), (unknown), Pieter Annaert, Bibiana Verlindo de Araújo	0
4	Tankyrase1/2 inhibitor XAV-939 reverts EMT and suggests that PARylation partially regulates aerobic activities in human hepatocytes and HepG2 cells 2024 ·Biochemical Pharmacology ·Kristof De Vos, (unknown), Justina C. Wolters, Susan Schlenner, Keimpe Wierda, (unknown), (unknown), (unknown), (unknown), Maarten Jacquemyn, Nikky Corthout, Dirk Daelemans, Pieter Annaert	1
5	Second generation Al18F-labeled D-amino acid peptide for CXCR4 targeted molecular imaging 2024 ·Nuclear Medicine and Biology ·(unknown), (unknown), Tom Van Loy, Mike Sathekge, Christophe M. Deroose, Michel Koole, Dominique Schols, Wim Vanduffel, Kristof De Vos, Pieter Annaert, Guy Bormans, Frederik Cleeren	3
6	Dose Adjustment in Patients with Liver Cirrhosis – Comparison of Two Different Modeling Approaches 2023 ·Clinical Pharmacology & Therapeutics ·(unknown), (unknown), Urs Duthaler, Pieter Annaert, Stephen Fowler, Kenichi Umehara, Neil Parrott, Stephan Krähenbühl	9
7	Unravelling the Hepatic Elimination Mechanisms of Colistin 2023 ·Pharmaceutical Research ·Bing Qi, Matthias Gijsen, (unknown), (unknown), (unknown), (unknown), (unknown), Joost Wauters, Isabel Spriet, Pieter Annaert	1
8	Meropenem Target Attainment and Population Pharmacokinetics in Critically Ill Septic Patients with Preserved or Increased Renal Function 2022 ·SHILAP Revista de lepidopterología ·Matthias Gijsen, (unknown), Pieter Annaert, Ruth Van Daele, Philippe Meersseman, Yves Debaveye, Joost Wauters, Erwin Dreesen, Isabel Spriet	18
9	Serum Creatinine Patterns in Neonates Treated with Therapeutic Hypothermia for Neonatal Encephalopathy 2022 ·Neonatology ·Elif Keleş, Pia Wintermark, Floris Groenendaal, (unknown), Anne Smits, Annouschka Laenen, Djalila Mekahli, Pieter Annaert, (unknown), Mehmet Yekta Öncel, Valerie Y. Chock, Didem Armangil, Esin Koç, Malcolm Battin, Adam Frymoyer, Karel Allegaert	12
10	Development of a Pig Mammary Epithelial Cell Culture Model as a Non-Clinical Tool for Studying Epithelial Barrier—A Contribution from the IMI-ConcePTION Project 2021 ·Animals ·Chiara Bernardini, (unknown), Roberta Salaroli, Augusta Zannoni, (unknown), (unknown), Domenico Ventrella, Maria Laura Bacci, Giuseppe Sarli, (unknown), Pieter Annaert, Monica Forni	6
11	Current knowledge, challenges and innovations in developmental pharmacology: A combined conect4children Expert Group and European Society for Developmental, Perinatal and Paediatric Pharmacology White Paper 2021 ·British Journal of Clinical Pharmacology ·Anne Smits, Pieter Annaert, Giacomo Cavallaro, Pieter De Cock, Saskia N. de Wildt, Jenny M. Kindblom, Florian B. Lagler, Carmen Moreno, Pavla Pokorná, Michiel F. Schreuder, Joseph F. Standing, M. Turner, Benedetto Vitiello, Wei Zhao, (unknown), Raffaella Willmann, John van den Anker, Karel Allegaert	30
12	Biomarkers of Cholestasis 2021 ·Biomarkers in Medicine ·(unknown), Eva Gijbels, Bruno Cogliati, Pieter Annaert, Lindsey Devisscher, Mathieu Vinken	20
13	Meropenem Stability in Human Plasma at −20 °C: Detailed Assessment of Degradation 2021 ·Antibiotics ·Matthias Gijsen, (unknown), Pieter Annaert, (unknown), Yves Debaveye, Joost Wauters, Peter Slaets, Isabel Spriet	10
14	Quantitative determination of colistin A/B and colistin methanesulfonate in biological samples using hydrophilic interaction chromatography tandem mass spectrometry 2020 ·Drug Testing and Analysis ·Bing Qi, Matthias Gijsen, (unknown), (unknown), (unknown), (unknown), (unknown), Joost Wauters, Isabel Spriet, Pieter Annaert	19
15	A sensitive liquid chromatography method for analysis of propofol in small volumes of neonatal blood 2019 ·Journal of Clinical Pharmacy and Therapeutics ·Bing Qi, Johan Nicolaï, Anne Smits, (unknown), (unknown), (unknown), Karel Allegaert, Pieter Annaert	5
16	Current insights in the complexities underlying drug-induced cholestasis 2019 ·Critical Reviews in Toxicology ·(unknown), (unknown), Bing Qi, (unknown), Eva Gijbels, Mathieu Vinken, Peter de Witte, Thomas Bouillon, Pieter Annaert	20
17	Sildenafil crosses the placenta at therapeutic levels in a dually perfused human cotyledon model 2018 ·American Journal of Obstetrics and Gynecology ·Francesca Maria Russo, (unknown), Karel Allegaert, Tim Van Mieghem, Jaan Toelen, Kristel Van Calsteren, Pieter Annaert, Jan Deprest	20
18	Antenatal sildenafil administration to prevent pulmonary hypertension in congenital diaphragmatic hernia (SToP-PH): study protocol for a phase I/IIb placenta transfer and safety study 2018 ·Trials ·Francesca Maria Russo, Alexandra Benachi, Tim Van Mieghem, Jan de Hoon, Kristel Van Calsteren, Pieter Annaert, Jean‐Marc Tréluyer, Karel Allegaert, Jan Deprest	28
19	Pretransplant 4β‐hydroxycholesterol does not predict tacrolimus exposure or dose requirements during the first days after kidney transplantation 2017 ·British Journal of Clinical Pharmacology ·Thomas Vanhove, Mahmoud Hasan, Pieter Annaert, Stefan Oswald, Dirk Kuypers	8
20	Lipophilic nalmefene prodrugs to achieve a one-month sustained release 2016 ·Journal of Controlled Release ·(unknown), Michel Guillaume, Herman Borghys, L.L. de Zwart, Ronald de Vries, (unknown), An Vermeulen, Anton A. H. P. Megens, Josée E. Leysen, Piet Herdewijn, Pieter Annaert, John Atack	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact